|
Jul 29
|
Bavarian Nordic agrees to $3B take-private deal
|
|
Jul 28
|
Bavarian Nordic Agrees to $2.99 Billion Private-Equity Takeover
|
|
Jul 28
|
Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic
|
|
Jul 24
|
Rumours of a Potential Takeover Offer for Bavarian Nordic A/S
|
|
Jul 22
|
Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine
|
|
Jun 30
|
AHF Urges Vaccine Equity as Mpox Cases Surge in Sierra Leone
|
|
Jun 26
|
Bavarian Nordic begins mpox vaccine trial in pregnant women and infants
|
|
May 16
|
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
|
|
May 13
|
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
|
|
May 12
|
Bavarian Nordic AS (BVNKF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
May 12
|
Undiscovered European Gems Including 3 Promising Small Caps
|
|
Apr 16
|
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
|
|
Mar 12
|
Bavarian Nordic A/S – Notice Convening Annual General Meeting
|
|
Feb 19
|
Undiscovered Gems And 2 Other Promising Small Caps With Strong Potential
|
|
Feb 17
|
Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens
|